raising questions about FDA's drug approval and surveillance process

A firestorm of press is raising questions about FDA's drug approval and surveillance process.

It started with the Vioxx revelations. Now an FDA insider is naming several more drugs with safety concerns.

Bextra (valdecoxib) might increase the risk of heart attack... similar to Vioxx. FDA was quick to add a contraindication for patients having bypass surgery. FDA also added a new "black box" warning about serious skin reactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote